Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...

Beyond the heart, the study hints that other transplantable organs could benefit from improved cold storage methods using a simple diuretic.

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime editing-based pipeline focus to liver disease and programs funded by external ...

Regeneron to acquire nearly all of 23andMe’s assets for $256M, marking a new chapter for the direct-to-consumer genetic testing pioneer.

Artificial intelligence is changing the skills needed to succeed. A digitally-literate workforce is absolutely critical.

Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.

BioMarin agreed to shell out approximately $270 million for Inozyme Pharma, a developer whose treatments target the PPi-adenosine pathway, a key regulator of bone health and blood vessel function.

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...